Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...
May 6 (Reuters) - Sanofi (SASY.PA), opens new tab has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the regulator's new fast-track review program, STAT News reported on ...
FILE PHOTO: The logo of French drugmaker Sanofi is seen in Paris, France, January 9, 2026. REUTERS/Gonzalo Fuentes/File Photo May 6 (Reuters) - Sanofi has asked the U.S. Food and Drug Administration ...
Add Yahoo as a preferred source to see more of our stories on Google. McDonald’s rolled out a new value menu Tuesday, but the chain may have also served customers a side of disappointment by ending a ...
Health clinics that rely on the Title X program have received their government funding for the year, following a chaotic and unorthodox application process that led to a brief delay and widespread ...
In the fall of 2023, Ilya Sutskever, OpenAI’s chief scientist, sent secret memos to three fellow-members of the organization’s board of directors. For weeks, they’d been having furtive discussions ...
Carter accumulated 14 points (5-12 FG, 3-7 3Pt, 1-2 FT), three rebounds, four assists and one steal across 25 minutes during Thursday's 121-117 loss to the Magic. Carter was one of six Sacramento ...
Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...
While everyone wants the Baltimore Ravens to re-sign center Tyler Linderbaum, one stat shows that maybe they should go in a different direction. There are a lot of experts out there who want the ...
Chicago's rodent problem is well known, but a new pilot program testing rat birth control to curb the population in problem areas is underway to help rein it in. The concept behind the program is ...
A new study has uncovered new genetic rules that determine how CD8 “killer” T cells choose between becoming long-lasting, protective immune cells or slipping into exhausted, dysfunctional states.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results